Clinical Trial Update: Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects [Phase 4]

View source ↗

Summary

Phase 4 extension study update for albiglutide in type 2 diabetes to assess long-term safety, tolerability, and pharmacodynamics; study terminated with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Albiglutide (albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2018-03-14